349 related articles for article (PubMed ID: 23076968)
21. Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults.
Altarabsheh SE; Dearani JA; Burkhart HM; Schaff HV; Deo SV; Eidem BW; Ommen SR; Li Z; Ackerman MJ
Ann Thorac Surg; 2013 Feb; 95(2):663-9; discussion 669. PubMed ID: 23040828
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study.
Jensen MK; Almaas VM; Jacobsson L; Hansen PR; Havndrup O; Aakhus S; Svane B; Hansen TF; Køber L; Endresen K; Eriksson MJ; Jørgensen E; Amlie JP; Gadler F; Bundgaard H
Circ Cardiovasc Interv; 2011 Jun; 4(3):256-65. PubMed ID: 21540441
[TBL] [Abstract][Full Text] [Related]
23. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
[TBL] [Abstract][Full Text] [Related]
24. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.
Maron BJ; Yacoub M; Dearani JA
Eur Heart J; 2011 May; 32(9):1055-8. PubMed ID: 21324934
[TBL] [Abstract][Full Text] [Related]
25. Survival of patients ≤ 50 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Krejčí J; Tomašov P; Jahnlová D; Honěk T; Januška J; Branny M; Zemánek D
Can J Cardiol; 2014 Jun; 30(6):634-8. PubMed ID: 24882534
[TBL] [Abstract][Full Text] [Related]
26. Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy?
Quintana E; Sabate-Rotes A; Maleszewski JJ; Ommen SR; Nishimura RA; Dearani JA; Schaff HV
J Thorac Cardiovasc Surg; 2015 Jul; 150(1):159-67.e1. PubMed ID: 25940414
[TBL] [Abstract][Full Text] [Related]
27. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
[TBL] [Abstract][Full Text] [Related]
28. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
Alam M; Dokainish H; Lakkis NM
Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
[TBL] [Abstract][Full Text] [Related]
29. Comparison of surgical septal myectomy to medical therapy alone in patients with hypertrophic cardiomyopathy and syncope.
Orme NM; Sorajja P; Dearani JA; Schaff HV; Gersh BJ; Ommen SR
Am J Cardiol; 2013 Feb; 111(3):388-92. PubMed ID: 23168291
[TBL] [Abstract][Full Text] [Related]
30. The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.
Samardhi H; Walters DL; Raffel C; Rateesh S; Harley C; Burstow D; Pohlner P; Aroney C
Catheter Cardiovasc Interv; 2014 Feb; 83(2):270-7. PubMed ID: 23873660
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.
Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Januska J; Krejci J; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg JM; Veselka J
JACC Cardiovasc Interv; 2017 Jun; 10(11):1134-1143. PubMed ID: 28595881
[TBL] [Abstract][Full Text] [Related]
32. Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures.
Dörge H; Schmitto JD; Liakopoulos OJ; Walther S; Schöndube FA
Thorac Cardiovasc Surg; 2004 Dec; 52(6):344-8. PubMed ID: 15573275
[TBL] [Abstract][Full Text] [Related]
33. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Poon SS; Field M; Gupta D; Cameron D
Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
[TBL] [Abstract][Full Text] [Related]
34. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
[TBL] [Abstract][Full Text] [Related]
35. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
36. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy.
Woo A; Williams WG; Choi R; Wigle ED; Rozenblyum E; Fedwick K; Siu S; Ralph-Edwards A; Rakowski H
Circulation; 2005 Apr; 111(16):2033-41. PubMed ID: 15824202
[TBL] [Abstract][Full Text] [Related]
37. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
Kuhn H; Lawrenz T; Lieder F; Leuner C; Strunk-Mueller C; Obergassel L; Bartelsmeier M; Stellbrink C
Clin Res Cardiol; 2008 Apr; 97(4):234-43. PubMed ID: 18071624
[TBL] [Abstract][Full Text] [Related]
38. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
[TBL] [Abstract][Full Text] [Related]
39. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
[TBL] [Abstract][Full Text] [Related]
40. Clinical Characteristics and Outcome of Alcohol Septal Ablation With Confirmation by Nitroglycerin Test for Drug-Refractory Hypertrophic Obstructive Cardiomyopathy With Labile Left Ventricular Outflow Obstruction.
Kitamura M; Takayama M; Matsuda J; Kubota Y; Nakamura S; Takano H; Asai K; Shimizu W
Am J Cardiol; 2015 Sep; 116(6):945-51. PubMed ID: 26209114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
